Method for extracting and separating high-purity wild baicalin from breviscapinun
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHENGDU PUSH BIOLOGICAL TECH
- Publication Date
- 2010-09-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention discloses a method for quickly separating a large amount of high-purity scutellarin from scutellarin, and belongs to the technical field of extraction and separation of effective components in plants. Background technique
[0002] Erigeron breviscapus (Vant.) Hand.-Mazz., also known as Erigeron breviscapus (Vant.) Hand.-Mazz. Scutellarin, etc., wherein the content of scutellarin (Scutellarin) is about 80% (HPLC method detection) is its main active ingredient, also known as scutellarin, scutellarin, chemical name 3', 5, 6-tri Hydroxy-7-O-glucuronide, molecular formula C 21 h 18 o 12 , the structural formula is shown in formula I.
[0003] Formula I
[0004] Breviscapine has a significant clinical effect in the treatment of cardiovascular and cerebrovascular diseases, and has a large demand. It has been developed into various dosage forms such as injections, tablets, and capsules. Because scutellarin has poor water solubility and fa...